Samer Al Hadidi, M.D., has joined the Myeloma Center in the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS), where he will treat patients with myeloma and other plasma cell disorders, the institute announced.
“I’m very happy to welcome Dr. Al Hadidi to our staff,” said Frits van Rhee, M.D., Ph.D., clinical director of the Myeloma Center. “I believe he will be a strong addition to our team.”
Al Hadidi is accepting new patients. He will also serve as an assistant professor in the UAMS College of Medicine Department of Hematology and Oncology.
Before joining UAMS, Al Hadidi recently completed his fellowship in hematology/oncology from Baylor College of Medicine in Houston, where he focused on cell and gene therapy. He completed his residency in internal medicine at Michigan State University in Flint, Michigan, and received a master’s degree in clinical research and statistical analysis from the University of Michigan in Ann Arbor.
Al Hadidi, a native of Al-Salt, Jordan, received his medical degree from School of Medicine, University of Jordan, in Amman.
